IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19

Updated on: April 16,2024

IgA antibodies seem to protect unvaccinated against COVID-19

by University of GothenburgT-cell populations that responded to stimulation with SARS-CoV-2 peptides. PBMC from individuals with IgG-dominated, IgA-dominated, and no antibody response to Covid-19

Updated on:April 16,2024

Type III interferon in COVID-19: Protective or harmful?

by Children's Hospital BostonCredit: CC0 Public DomainOur immune system makes interferons and other cytokines to help us fight viruses. But in COVID-19, we've learned that they can also c

Updated on: April 16,2024

Type III interferon in COVID-19: Protective or harmful?

by Children's Hospital BostonCredit: CC0 Public DomainOur immune system makes interferons and other cytokines to help us fight viruses. But in COVID-19, we've learned that they can also c

Updated on:April 16,2024

Clinical Pearl Series:Special Viral Infection by Coronaviruses

Updated on: April 13,2024

Clinical Pearl Series:Special Viral Infection by Coronaviruses

Updated on:April 13,2024

COVID-19: Anti-viral strategy with double effect

by Brigitte Holfelder,Max Planck SocietyThe protease PLpro of Sars-CoV-2 plays a central role in the viral life cycle. By cleaving also proteins of infected cells, PLpro interferes with the inna

Updated on: April 12,2024

COVID-19: Anti-viral strategy with double effect

by Brigitte Holfelder,Max Planck SocietyThe protease PLpro of Sars-CoV-2 plays a central role in the viral life cycle. By cleaving also proteins of infected cells, PLpro interferes with the inna

Updated on:April 12,2024

COVID-19 vaccination shown to protect people with blood cancer

by Ludwig Maximilian University of MunichStudy time chart, anti-spike IgG levels and IgG avidity in individuals with hematologic neoplasia and in healthy individuals at different time points afte

Updated on: April 12,2024

COVID-19 vaccination shown to protect people with blood cancer

by Ludwig Maximilian University of MunichStudy time chart, anti-spike IgG levels and IgG avidity in individuals with hematologic neoplasia and in healthy individuals at different time points afte

Updated on:April 12,2024

COVID-19 cytokine storms may prevent a durable immune response

by Rachel Leeson,Massachusetts General HospitalCredit: CC0 Public DomainShiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical Schoo

Updated on: April 12,2024

COVID-19 cytokine storms may prevent a durable immune response

by Rachel Leeson,Massachusetts General HospitalCredit: CC0 Public DomainShiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical Schoo

Updated on:April 12,2024

Antibodies elicited by COVID-19 vaccination effective against delta variant

by Tamara Bhandari,Washington University School of Medicine in St. LouisCherry Grimmett, a BJC HealthCare security officer, receives her first dose of the Pfizer COVID-19 vaccine in December 202

Updated on: April 12,2024

Antibodies elicited by COVID-19 vaccination effective against delta variant

by Tamara Bhandari,Washington University School of Medicine in St. LouisCherry Grimmett, a BJC HealthCare security officer, receives her first dose of the Pfizer COVID-19 vaccine in December 202

Updated on:April 12,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on: April 12,2024

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on:April 12,2024

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe

Updated on: April 12,2024

COVID-19 vaccine responses to be studied in people with immune deficits

by NIH/National Institute of Allergy and Infectious DiseasesZebra-print ribbon, a symbol for awareness of primary immunodeficiencies and other rare diseases. Credit: NIAIDA study assessing how pe

Updated on:April 12,2024

Does the COVID-19 cytokine storm exist?

by Radboud UniversityCredit: CC0 Public DomainInflammatory proteins, also known as cytokines, play a crucial role in the immune response. If this immune response is too strong, a phenomenon known

Updated on: April 12,2024

Does the COVID-19 cytokine storm exist?

by Radboud UniversityCredit: CC0 Public DomainInflammatory proteins, also known as cytokines, play a crucial role in the immune response. If this immune response is too strong, a phenomenon known

Updated on:April 12,2024

Loss of smell following COVID linked to a person's immune reaction to the infection

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainA team of researchers from Columbia University Irving Medical Center, the University of Pennsylvania, the National Institute of Alcohol Ab

Updated on: April 12,2024

Loss of smell following COVID linked to a person's immune reaction to the infection

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainA team of researchers from Columbia University Irving Medical Center, the University of Pennsylvania, the National Institute of Alcohol Ab

Updated on:April 12,2024

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h

Updated on: April 12,2024

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h

Updated on:April 12,2024